Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.77
+0.61 (1.32%)
At close: Mar 9, 2026, 4:00 PM EDT
46.74
-0.03 (-0.06%)
After-hours: Mar 9, 2026, 4:10 PM EDT
KNSA Employees
Kiniksa Pharmaceuticals International, had 366 employees as of December 31, 2025. The number of employees increased by 51 or 16.19% compared to the previous year.
Employees
366
Change (1Y)
51
Growth (1Y)
16.19%
Revenue / Employee
$1,851,268
Profits / Employee
$161,216
Market Cap
3.58B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,780 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 674 |
KNSA News
- 12 days ago - Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 13 days ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 18 days ago - Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 6 weeks ago - Kiniksa: Arcalyst Is The Engine, But KPL-387 Is The Accelerator - Seeking Alpha
- 7 weeks ago - Kiniksa Pharmaceuticals International, plc (KNSA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Kiniksa Pharmaceuticals Provides Corporate Update - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire